A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/27 (2006.01) A61K 9/08 (2006.01) A61K 9/10 (2006.01) A61K 47/30 (2006.01)
Patent
CA 2544049
The invention relates to a novel pharmaceutical formulation containing an LTB4 antagonist of formula (I), wherein A, R1, R2, R3, and R4 have the meaning indicated in claim 1, the pharmacologically acceptable acid addition salt thereof, glycoside, O-sulfate, or glucuronide as an active substance, and at least one optional pharmacologically acceptable auxiliary agent and/or carrier, the active substance being provided as a solid solution or solid dispersion in a polymer matrix. The invention also relates to the production thereof, the use thereof as a medicament, and said solid solutions and dispersions.
L'invention concerne une nouvelle formulation de médicament contenant un antagoniste de LTB¿4? de formule (I) dans laquelle A, R¿1?, R¿2?, R¿3? et R¿4? sont tels que définis dans la première revendication, ou un sel d'addition acide pharmacologiquement acceptable, glycoside, O-sulfate ou glucoronide de cet antagoniste, en tant que principe actif, et comprenant en outre éventuellement au moins un adjuvant et/ou support pharmacologiquement acceptable. Selon l'invention, le principe actif se présente sous la forme d'une solution solide ou dispersion solide dans une matrice polymère. Cette invention se rapporte également à la production de cette formulation, et à son utilisation en tant que médicament, ainsi qu'auxdites solutions et dispersions solides.
Bock Thomas
Brauns Ulrich
Moll Siglinde
Weber Karl
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Pharmaceutical formulation containing an ltb4 antagonist,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation containing an ltb4 antagonist,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation containing an ltb4 antagonist,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1436066